These studies found that increasing the avidity of the anti-HA response can improve the breadth and potency of anti-influenza immunity and that harnessing the B cell CD23-FcγRIIb axis can be done to improve immunity elicited by existing seasonal influenza virus vaccines. Here, FCER2 is linked to influenza.